Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
EVENTS PER QUARTER · HOVER FOR EMPLOYEE COUNTS
Thermo Fisher Scientific Inc. has announced the closure of its plant in Franklin, Massachusetts, which will affect over 100 jobs. This decision comes as part of the company's restructuring efforts. The layoffs are a response to ongoing operational adjustments within the company. Employees at the Franklin facility will be impacted, although specific details regarding the timeline for the closure have not been disclosed. This move reflects broader trends in the industry as companies adapt to changing market conditions.
Thermo Fisher Scientific Inc. has announced the closure of its Franklin site, which will result in the layoff of up to 80 workers. This decision reflects the company's ongoing restructuring efforts as it adapts to changing market conditions. The closure is part of a broader strategy to streamline operations and improve efficiency. Employees affected by this decision will be notified as the company moves forward with the closure plans. The exact timeline for the closure has not been specified, but it is expected to impact the workforce significantly.
Thermo Fisher Scientific Inc. has announced the closure of its Franklin plant, resulting in the layoff of 80 workers. This decision reflects the company's ongoing restructuring efforts as it aims to streamline operations. The layoffs are set to take effect on October 31, 2023. The closure of the facility is part of a broader strategy to optimize the company's resources and enhance efficiency. Employees affected by this decision have been notified, and the company is working to support them during this transition.
Thermo Fisher Scientific has announced the closure of its factory in North Carolina, resulting in the layoff of over 400 employees. This decision comes as part of a restructuring effort aimed at optimizing operations. The layoffs are expected to take effect on October 1, 2023, impacting a significant portion of the workforce at the facility. The company has not specified the reasons behind the closure but indicated that it is part of a broader strategy to enhance efficiency. This move raises concerns about the local job market and the future of the affected employees.
Thermo Fisher Scientific Inc. has announced the closure of its Asheville plant, resulting in the layoff of 421 workers. This decision is part of a strategic shift aimed at optimizing operations and reducing costs. The company cited the need to streamline its manufacturing processes as a key reason for the closure. Employees affected by the layoffs will be notified and provided with support during this transition. The closure is expected to take effect in early October 2023, marking a significant reduction in the company's workforce in the region.
Thermo Fisher Scientific Inc. is set to reduce its workforce by approximately 100 employees due to the closure of its Franklin site in Massachusetts. This decision is part of a broader strategy to streamline operations and enhance efficiency within the company. The layoffs are expected to take effect in early October 2023, impacting the local workforce significantly. The closure reflects ongoing adjustments in the company's operational footprint as it adapts to changing market conditions. Thermo Fisher has not specified if any particular departments will be more affected than others, but the overall reduction highlights the company's commitment to optimizing its resources.
Thermo Fisher Scientific Inc. has laid off 300 workers at its facility in Massachusetts as part of ongoing workforce reductions. This decision follows previous layoffs and is part of the company's strategy to streamline operations amid changing market conditions. The layoffs are aimed at improving efficiency and aligning resources with current business needs. The company has not specified the departments affected by these cuts, but the layoffs are significant for the local workforce. This move reflects broader trends in the industry as companies adjust to economic pressures.
Thermo Fisher Scientific has announced plans to lay off hundreds of workers as it phases out operations in Weaverville, North Carolina. The company is expected to cut approximately 300 positions as part of this transition. This decision comes as Thermo Fisher seeks to streamline its operations and focus on its core business areas. The layoffs are part of a broader restructuring effort, although specific timelines for the job cuts have not been disclosed. The company has not provided detailed reasons for the closure of the Weaverville facility, but it reflects ongoing adjustments in response to market demands.
Thermo Fisher Scientific has announced plans to lay off dozens of employees as part of a restructuring effort that includes the closure of its facility in Massachusetts. The company is expected to eliminate approximately 36 positions, although specific details regarding the timeline for these layoffs have not been disclosed. This decision reflects ongoing adjustments within the company as it navigates current market conditions. The closure of the Massachusetts facility is part of a broader strategy to optimize operations and reduce costs.
Thermo Fisher Scientific Inc. has announced plans to lay off dozens of employees as part of a restructuring effort that includes the closure of its facility in Massachusetts. The company is expected to affect approximately 36 positions, although specific details regarding the timeline for these layoffs have not been disclosed. This decision comes amid broader challenges within the biotech industry, prompting the company to reevaluate its operational footprint. The layoffs reflect ongoing adjustments in response to market conditions and operational efficiency goals.
Thermo Fisher Scientific has announced plans to end operations at its Weaverville site in North Carolina. This decision is part of a broader restructuring strategy aimed at optimizing its operations. While the exact number of employees affected has not been disclosed, the closure indicates significant changes at the facility. The company has not provided a specific timeline for when the operations will cease. This move reflects ongoing adjustments within the organization to enhance efficiency and align with market demands.
Thermo Fisher Scientific Inc. has announced plans to lay off approximately 300 workers as it phases out operations in Weaverville, North Carolina. The decision is part of a broader restructuring effort aimed at optimizing the company's operational efficiency. The layoffs are expected to impact the local workforce significantly, although specific timelines for the job cuts have not been disclosed. This move reflects the company's ongoing adjustments in response to market conditions and operational needs.
Thermo Fisher Scientific Inc. is preparing for upcoming layoffs as part of its strategic adjustments in response to market conditions. The company has not specified the number of employees affected or the exact timeline for these layoffs. This decision comes after a recent decline in stock prices, prompting traders to evaluate the company's operational efficiency. While details remain sparse, the planned workforce reduction reflects broader trends in the industry as companies navigate economic challenges.
Thermo Fisher Scientific Inc. is set to close its facility in Franklin, which will result in up to 80 layoffs. The closure plan has been announced, indicating that the layoffs are forthcoming. This decision is part of the company's broader restructuring efforts. The specific reasons for the closure and layoffs have not been detailed, but the move reflects ongoing adjustments within the company. The impact of these layoffs on the local workforce and the company's operations remains to be seen.
No one has shared a story from Thermo Fisher Scientific Inc yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →We'll email you the moment a new layoff is reported here.